Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth Sells 4,000 Shares

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 4,000 shares of the company’s stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares in the company, valued at $4,415,201.28. This trade represents a 3.26 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, March 4th, Margaret Tooth sold 2,294 shares of Trupanion stock. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66.

Trupanion Trading Down 2.1 %

Shares of TRUP opened at $37.80 on Wednesday. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The stock’s 50-day moving average is $41.42 and its two-hundred day moving average is $46.67. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The stock has a market cap of $1.61 billion, a PE ratio of -164.35, a P/E/G ratio of 6.02 and a beta of 1.70.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. Equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on TRUP shares. Piper Sandler dropped their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th. Stifel Nicolaus cut their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.

Hedge Funds Weigh In On Trupanion

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp lifted its stake in shares of Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 238 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Trupanion by 18.5% in the 4th quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock valued at $82,000 after purchasing an additional 267 shares in the last quarter. Coppell Advisory Solutions LLC boosted its stake in shares of Trupanion by 58.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider’s stock valued at $61,000 after buying an additional 460 shares during the last quarter. SBI Securities Co. Ltd. acquired a new stake in shares of Trupanion during the fourth quarter worth approximately $25,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Trupanion by 7.3% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,861 shares of the financial services provider’s stock worth $414,000 after buying an additional 671 shares during the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.